Showing 696 results
-
Media Release /
-
Media Release /-- Regulatory applications to be submitted worldwide for RAD001 first submissions filed in the Hidden List US, EU and Switzerland -- Data showing that RAD001 more than doubles time without tumor…
-
Media Release /
-
Media Release /Jury verdict in Montgomery County Circuit Court awards $33 million in compensatory damagesJury decides in favor of Novartis and rejects claims for punitive damagesNPC maintains it reported true and…
-
Media Release /
-
Media Release /- Efficacy and safety profile in large randomized Phase III study consistent with landmark IRIS trial, which established Gleevec as standard of care- Study did not meet primary endpoint at 1 year,…
-
Media Release /
-
Media Release /
-
Media Release /- Zometa when added to hormone therapy, following surgery, significantly reduced the risk of cancer returning or death by 36% beyond clinical benefits achieved with hormone therapy alone(1)- Findings…
-
Media Release /
